Navigation Links
High-sensitivity bone marrow aspiration technology enhances leukemia cell detection
Date:10/6/2009

PHILADELPHIA Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow.

Superconducting Quantum Interference Device (SQUID) enhanced the ability to rapidly quantify the amount of nanoparticle bound tumor cells in a sample at least 10 fold, and increased sensitivity of minimal residual disease measurements. Results of this proof-of-concept study are published in Cancer Research, a journal of the American Association for Cancer Research.

"This promises to significantly enhance the detection for residual disease in leukemia and other cancers," said lead scientist Richard S. Larson, M.D., Ph.D., vice president for translation research at the University of New Mexico Health Science Center. "Coupling nanotechnology can be employed in common techniques to enhance its utility."

These findings are a result of a collaborative research effort between Senior Scientific, LLC, and the University of New Mexico. The study was funded by a small business innovation grant awarded by the National Cancer Institute.

Previous studies have indicated that the magnetic needle can collect approximately 80 percent of leukemia cells in a bone marrow sample in a matter of minutes, according to Edward R. Flynn, Ph.D., president and CEO of Senior Scientific, LLC.

The scientists developed this magnetic marrow biopsy needle in an effort to target tumor cells with nanoparticles and then preferentially extract the tumor cells with a magnetic needle. They used anti-CD34 antibody loaded magnetic nanoparticles to detect CD34+ cells as an indicator of leukemia. To quantify the cells recovered, they coupled this nanoparticle-mediated fishing for leukemic cells with SQUID.

SQUID enhanced the sensitivity of measuring minimal residual disease over standard pathology methods for patients undergoing chemotherapy.

"This result will determine more precisely the effect of the chemotherapy a
'/>"/>

Contact: Tara Yates
tara.yates@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
2. Save a Life: Join the Kiel Mortgage Marrow-thon on September 23
3. Help Save a Life - Bone Marrow Donor Registry Drive Sept. 2 at the Karmanos Cancer Center
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Cerebral Palsy Improves After Bone Marrow Stem Cell Procedure
6. Ready for relapse: Molecule helps breast cancer cells to survive in the bone marrow
7. Trimming the fat boosts blood recovery after marrow transplant
8. National Marrowthon Campaign Aims to Bring Nearly 50,000 to the Be The Match Registry(SM) in Two Weeks
9. Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign
10. Bone marrow stem cell co-transplantation prevents embryonic stem cell transplant-associated tumors
11. Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High-sensitivity bone marrow aspiration technology enhances leukemia cell detection
High-sensitivity bone marrow aspiration technology enhances leukemia cell detection
(Date:11/21/2009)...21 Tonight, in a partis...or Reid,s version of the government takeover of he...ncluded in this bill; like the public option, empl...nding for elective abortion, which is the most one...ill provides subsidies for private plans that cove...
(Date:11/21/2009)...usses Key Provisions of Legislation, Continues Pus...ARLES, Ill., Nov. 21 ... landmark Affordable Health Care for America Act (...m legislation forward, Congress has taken decisive...em. Today, AARP hosted an educational forum to di...
(Date:11/21/2009)...c J. Hall, president and chief executive officer o...ed the following statement regarding the inclusion...new annual wellness for Medicare beneficiaries in ...ct" that was introduced last night: , ..., 2009 -- Eric J. Hall, president and chief execut...
(Date:11/20/2009)... 20 The American Acade...alth care reform legislation released this week to...rance individual coverage mandate. The actuaries s... minimize adverse selection stemming from more res...bill. ,, "The individual mandate language shoul...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The American Dental Asso...dministration (FDA) to establish appropriate class...iting concern about the safety of whitening produc... of professional consultation or examination by a ... of chemically based tooth whitening or bleaching ...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
... a gene that predict a high likelihood of relapse ...). Although the researchers caution that further r...gene, called IKZF1 or IKAROS, lead to leukemia rel...identify this genetic marker in ALL patients, phys...
...Patients Unable to Pay Out-of-Pocket Costs, 33 Per...ERs , , SACRAMENTO, Calif., Jan. 7 The econom...tic impact on California,s community hospitals, ac...ember 2008 among hospital chief financial officers...
...rates in Northeast, government reports , ,...rth rate in the United States increased in 26 of t...gion of the country, according to a new government...reased for the first time in 15 years in 2006 -- f...
...ecently awarded two core faculty members of the Jo...that will allow Drs. Gail Geller and Cynda Hylton ...rofessionals face while caring for children and fa...al HeartSongs Project funded by the Stavros Niarch...
...revolution emerges when,technology blends with sma...on,with its new Smart OR(TM) - a specialized neuro...t for neurosurgery, spine and trauma patients. , ...ps neurosurgeons perform complex brain, spine and ...
.... (NYSE: MED ), a leading portion-controlled wei...ed a Future 50 winner by Baltimore SmartCEO maga...ward. , , The Future 50 program recognizes the 5...ny expects revenues in excess of $100 million for ...
Other Medicine News:Health News:Gene abnormality found to predict childhood leukemia relapse 2Health News:Gene abnormality found to predict childhood leukemia relapse 3Health News:Gene abnormality found to predict childhood leukemia relapse 4Health News:Economic Downturn Takes Toll on California Hospitals 2Health News:Teen Birth Rate Up in 26 States in 2006 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2
(Date:11/20/2009).... 20 Biotel Inc. (OTC Bu...t quarter ended September 30, 2009 with net earnin...enues of $3,263,000. This compares to net earning...nues of $3,168,000 for the first quarter of last y..., Biotel President and CEO Steve Springrose said: ...
(Date:11/20/2009)...J., Nov. 20 Soligenix, I...ompany), formerly known as DOR BioPharma, Inc., a ...that it has formed a consortium to develop thermos...pidly acting vaccines. Soligenix received a $9.4 m...y and Infectious Diseases (NIAID), a division of t...
(Date:11/19/2009)...aiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a ...ngredients (APIs), announced that its,Tainan facil...ication from,SafeBridge(R) Consultants, Inc. The C...proficiency in the safe handling of potent active,...specific laboratories and,production areas used fo...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 21 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 1Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 2CardioGenics Holdings Inc Announces Letter to Shareholders 5757 1CardioGenics Holdings Inc Announces Letter to Shareholders 5757 2CardioGenics Holdings Inc Announces Letter to Shareholders 5757 3
... 15 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ),...(NDA) for Bepreve(TM) (bepotastine ophthalmic solu...d and Drug Administration (FDA). The Company is s...nt for ocular itching associated with allergic con...w of ten months and has been given a user fee acti...
...cts to respond to agency during first quarter , ,...ation (NYSE: SGP ) today announced that the U.S....omplete response letter for SAPHRIS(TM) (asenapine...izophrenia in adults and in the acute treatment of... disorder in adults as monotherapy. The action le...
Other Medicine Technology:ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration 2ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration 3U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder 2
...ry need. No matter the size of the incision or pat...Systems give you the best possible exposure in the... frame arms, along with the hinged extension arm, ...ompletely scalable access and excellent exposure f...
3M™ Littmann® Electronic Stethoscope Model 3000
CVC 9005 Hematocrit Calibration Verification Control (for use with the IRMA TRUpoint Blood Analysis System)
QC 823 Blood Gas, Electrolyte, Metabolite, BUN Control
Medicine Products: